These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2865973)
21. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets]. Nosál' R; Jancinová V; Petríková M Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390 [TBL] [Abstract][Full Text] [Related]
22. Beta-adrenoceptor blocking drugs and calcium transport in isolated rat mast cells. Drábiková K; Pecivová J; Nosál R Agents Actions; 1989 Apr; 27(1-2):33-5. PubMed ID: 2473626 [TBL] [Abstract][Full Text] [Related]
23. Membrane perturbing activity of beta-adrenoceptor blocking drugs in isolated rat mast cells. Nosál R; Drábiková K; Pecivová J; Ondrias K Agents Actions; 1989 Apr; 27(1-2):36-8. PubMed ID: 2473627 [TBL] [Abstract][Full Text] [Related]
24. Histamine liberation as a result of nonreceptor interaction. Nosál R; Drábiková K; Pecivová J; Jakubovský J Agents Actions; 1990 Apr; 30(1-2):74-6. PubMed ID: 1695466 [TBL] [Abstract][Full Text] [Related]
25. Effect of beta adrenergic blocking agents on erythropoiesis in rats. Zivný J; Ostádal B; Neuwirt J; Procházka J; Pelouch V J Pharmacol Exp Ther; 1983 Jul; 226(1):222-5. PubMed ID: 6134822 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the potency of five potential beta-adrenoceptor blocking drugs and eight calcium channel blockers to inhibit platelet aggregation and to perturb liposomal membranes prepared from platelet lipids. Ondriasová E; Ondrias K; Stasko A; Nosál R; Csöllei J Physiol Res; 1992; 41(4):267-72. PubMed ID: 1363058 [TBL] [Abstract][Full Text] [Related]
27. Involvement of arachidonic acid and its metabolites in the inhibitory effect of beta-adrenoceptor blocking drugs on blood platelets. Nosál R; Jancinová V; Petríková M Agents Actions Suppl; 1992; 37():47-52. PubMed ID: 1352937 [TBL] [Abstract][Full Text] [Related]
28. Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP. Winther K; Trap-Jensen J Eur J Clin Pharmacol; 1988; 35(1):17-20. PubMed ID: 2905989 [TBL] [Abstract][Full Text] [Related]
29. Effects of bupranolol, a new beta-blocker, on platelet functions of rabbit and human in vitro. Umetsu T; Sanai K; Kato T Thromb Haemost; 1976 Nov; 36(2):376-87. PubMed ID: 12593 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers. Gasser JA; Betterridge DJ J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976 [TBL] [Abstract][Full Text] [Related]
31. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611 [TBL] [Abstract][Full Text] [Related]
32. On the relationship between incorporation of 32P into phospholipids and binding of beta-adrenoceptor blocking drugs to isolated mast cells. Pecivová J; Drábiková K; Jancinová V; Nosál R Agents Actions; 1988 Apr; 23(3-4):146-8. PubMed ID: 2899380 [TBL] [Abstract][Full Text] [Related]
33. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats. Vanĕcek M; Trcka V; Helfert I Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106 [No Abstract] [Full Text] [Related]
34. The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients. Luque Otero M; Fernandez Pinilla C; Escriba Polo A; Rodriguez Vazquez M; Martell Claros N; Fernandez-Cruz A Br J Clin Pharmacol; 1984 Mar; 17(3):361-3. PubMed ID: 6143567 [TBL] [Abstract][Full Text] [Related]
35. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620 [TBL] [Abstract][Full Text] [Related]
36. Influence of beta-adrenoceptor blocking drugs on lipid-protein interaction in synaptosomal membranes. An ESR study. Ondrias K; Stasko A; Marko V; Nosál R Chem Biol Interact; 1989; 69(1):87-97. PubMed ID: 2563339 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals. Trcka V; Vanĕcek M; Helfert I; Mácová S Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104 [No Abstract] [Full Text] [Related]
39. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent. Miyagishi A; Nakahara H; Hara Y Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068 [TBL] [Abstract][Full Text] [Related]
40. Effects of calcium, lanthanum, and temperature on the fluidity of spin-labeled human platelets. Sauerheber RD; Zimmermann TS; Esgate JA; VanderLaan WP; Gordon LM J Membr Biol; 1980; 52(3):201-19. PubMed ID: 6247493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]